|
|
 |
|
Total Number of Holdings (excluding cash): 50
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
1,207 |
$82,667.43 |
2.78% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
3,103 |
$78,393.29 |
2.63% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
3,999 |
$73,268.48 |
2.46% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
162 |
$72,065.70 |
2.42% |
| Insulet Corporation |
PODD |
45784P101 |
356 |
$71,840.80 |
2.41% |
| Olympus Corporation |
7733.JP |
J61240107 |
4,440 |
$71,566.59 |
2.40% |
| Boston Scientific Corporation |
BSX |
101137107 |
916 |
$70,541.16 |
2.37% |
| Hoya Corporation |
7741.JP |
J22848105 |
594 |
$69,053.45 |
2.32% |
| Alcon Inc. |
ALC.SW |
H01301128 |
766 |
$68,393.92 |
2.30% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
49 |
$68,481.91 |
2.30% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
221 |
$68,283.83 |
2.29% |
| Steris Plc |
STE |
G8473T100 |
306 |
$67,179.24 |
2.26% |
| Cochlear Limited |
COH.AU |
Q25953102 |
301 |
$66,694.56 |
2.24% |
| Amplifon SpA |
AMP.IM |
T0388E118 |
1,867 |
$66,462.17 |
2.23% |
| Danaher Corporation |
DHR |
235851102 |
260 |
$64,961.00 |
2.18% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
5,216 |
$64,656.08 |
2.17% |
| ResMed Inc. |
RMD |
761152107 |
335 |
$64,125.70 |
2.15% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
691 |
$63,827.67 |
2.14% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
1,098 |
$63,263.59 |
2.13% |
| Revvity, Inc. |
RVTY |
714046109 |
602 |
$63,125.72 |
2.12% |
| Becton, Dickinson and Company |
BDX |
075887109 |
265 |
$61,933.15 |
2.08% |
| Stryker Corporation |
SYK |
863667101 |
182 |
$61,925.50 |
2.08% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
3,834 |
$61,739.16 |
2.07% |
| Medtronic Plc |
MDT |
G5960L103 |
778 |
$61,236.38 |
2.06% |
| Teleflex Incorporated |
TFX |
879369106 |
291 |
$61,206.03 |
2.06% |
| Terumo Corporation |
4543.JP |
J83173104 |
3,660 |
$60,347.53 |
2.03% |
| Hologic, Inc. |
HOLX |
436440101 |
806 |
$59,845.50 |
2.01% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
108 |
$59,724.00 |
2.01% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,372 |
$59,380.75 |
2.00% |
| Abbott Laboratories |
ABT |
002824100 |
571 |
$59,332.61 |
1.99% |
| The Cooper Companies, Inc. |
COO |
216648501 |
667 |
$58,229.10 |
1.96% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
482 |
$57,904.62 |
1.95% |
| Agilent Technologies, Inc. |
A |
00846U101 |
443 |
$57,426.09 |
1.93% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
208 |
$56,806.88 |
1.91% |
| Masimo Corporation |
MASI |
574795100 |
452 |
$56,924.88 |
1.91% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
723 |
$56,336.16 |
1.89% |
| Waters Corporation |
WAT |
941848103 |
193 |
$55,993.16 |
1.88% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
501 |
$54,373.53 |
1.83% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
164 |
$54,019.96 |
1.81% |
| BioMerieux |
BIM.FP |
F1149Y232 |
561 |
$53,321.27 |
1.79% |
| Baxter International Inc. |
BAX |
071813109 |
1,546 |
$51,713.70 |
1.74% |
| DexCom, Inc. |
DXCM |
252131107 |
458 |
$51,928.04 |
1.74% |
| Penumbra, Inc. |
PEN |
70975L107 |
287 |
$51,651.39 |
1.74% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
13,878 |
$51,893.52 |
1.74% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
410 |
$50,790.80 |
1.71% |
| Align Technology, Inc. |
ALGN |
016255101 |
198 |
$47,803.14 |
1.61% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
573 |
$40,286.42 |
1.35% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
229 |
$37,596.45 |
1.26% |
| Exact Sciences Corporation |
EXAS |
30063P105 |
855 |
$36,123.75 |
1.21% |
| US Dollar |
$USD |
|
7,133 |
$7,133.24 |
0.24% |
| Yuan Renminbi |
$CNY |
|
13,736 |
$1,890.06 |
0.06% |
| New Zealand Dollar |
$NZD |
|
1,109 |
$675.77 |
0.02% |
| Amplifon Spa-Rts |
2452113D.IM |
|
1,867 |
$0.04 |
0.00% |
| Euro |
$EUR |
|
0 |
$0.04 |
0.00% |
| Japanese Yen |
$JPY |
|
4,466 |
$27.76 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.09 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|